ECTRIMS 2018

Area: Neurology

Location: Berlin, Germany

Date: October 10 to October 12

Description:

34th European Commitee for Treatment and Research in Multiple Sclerosis.


Search in Scientific Content:
Date
Filters:
Durable ef
12:16

Durable efficacy of B- and T-cell targeting IRT: focus on Cladribine Tablets

Presenter: Andrew Chan
Neurology
The Essen
4:02

The Essen cohort

Presenter: Christoph Kleinschnitz
Neurology
Treatment
1:55

Treatment selection and switching: a road map Co-author of Dr. Jiwon Oh

Presenter: Eva Kubala Havrdov√°
Neurology

New therapies

Presenter: Jerry S. Wolinsky
Neurology
Sustained
15:34

Sustained efficacy in relapsing remitting multiple sclerosis following switch to placebo treatment from cladribine tablets in patients with high disease activity at baseline

Presenter: Patrick Vermersch
Neurology
A real-wor
2:18

A real-world comparison of infection rate and lymphocyte counts among relapsing-remitting multiple sclerosis patients 50 years or older treated with subcutaneous interferon beta-1a or dimethyl fumarate

Presenter: Sarah B Cardoso
Neurology
Inhibition
3:06

Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis

Presenter: Sebastian Torke
Neurology
Cladribine
6:22

Cladribine personalised dosing in people with MS (n>200) - four years experience in clinical care

Presenter: Stefania De Trane
Neurology
Updated sa
9:06

Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis

Presenter: Gavin Giovannoni
Neurology

AAIC 2016

2016-07-24 - 2016-07-28
Toronto, Canada